SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-015224
Filing Date
2018-08-10
Accepted
2018-08-10 16:09:38
Documents
49
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20180630_10q.htm 10-Q 1282570
2 EXHIBIT 31.1 ex_116600.htm EX-31.1 14498
3 EXHIBIT 31.2 ex_116601.htm EX-31.2 14580
4 EXHIBIT 32.1 ex_116602.htm EX-32.1 7044
5 EXHIBIT 32.2 ex_116603.htm EX-32.2 7311
  Complete submission text file 0001437749-18-015224.txt   4137545

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kmph-20180630.xml EX-101.INS 699412
7 XBRL TAXONOMY EXTENSION SCHEMA kmph-20180630.xsd EX-101.SCH 36797
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20180630_cal.xml EX-101.CAL 31276
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20180630_def.xml EX-101.DEF 269547
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20180630_lab.xml EX-101.LAB 222329
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20180630_pre.xml EX-101.PRE 279320
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 181008941
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1